Human excimer laser corneal surgery: preliminary report.
The first human trial utilizing the argon fluoride excimer laser at 193 nm to produce a superficial keratectomy in ten human eyes has been described with the histopathological evaluation of four eyes and the longer gross appearance of six eyes at intervals extending to 10 months post-excimer laser treatment. The process of laser superficial keratectomy has proved to be one of the promising areas of surgical intervention for reconstructive or refractive keratoplasty in the future. Intensive investigations need to be undertaken on the corneal wound healing process following laser ablation as well as the nature, and long-term stability of the corneal excisions or induced refractive corrections. It is essential that the optimal laser parameters be established for the various refractive corrections and other corneal surgical techniques, and that pathophysiologic and histopathologic changes that have been induced by the excimer laser-corneal tissue interaction in animals and humans be critically and extensively analyzed.
L'Esperance
F A
FA
Taylor
D M
DM
Del Pero
R A
RA
Roberts
A
A
Gigstad
J
J
Stokes
M T
MT
Warner
J W
JW
Telfair
W B
WB
Martin
C A
CA
Yoder
P R
PR
D000328:Adult; D000368:Aged; D000818:Animals; D001766:Blindness / Q000601:surgery; D002986:Clinical Trials as Topic; D003315:Cornea / Q000473:pathology / Q000601:surgery* / Q000648:ultrastructure; D016039:Corneal Transplantation; D005134:Eye Neoplasms / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000473:pathology / Q000601:surgery; D006801:Humans; D007646:Keratotomy, Radial; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000601:surgery; D014466:Ultraviolet Rays